SAMUEL T. R. REVELL JR., M.D., F.A.C.P.; FRANCIS J. BORGES, M.D.; GEORGE H. YEAGER, M.D., F.A.C.S.; JAMES G. ARNOLD JR., M.D.; RICHARD I. AHLQUIST JR., M.D.
This content is PDF only. Please click on the PDF icon to access.
During the past two and one-half years our group has studied 17 patients in the malignant phase of essential hypertension. Our initial objectives were: (1) to establish rigid criteria for selection of patients in order that comparisons would be valid; (2) to determine if it were possible to reverse the renal insufficiency so common in this disease; (3) to compare the results of adrenalectomy with the combined procedure of adrenalectomy and sympathectomy.
The criteria used in the selection of these patients were: a rapidly progressive hypertensive state, papilledema with hemorrhagic exudates, and the absence of any demonstrable primary etiology for
REVELL STR, BORGES FJ, YEAGER GH, et al. SYMPATHO-ADRENAL SURGERY IN THE MALIGNANT PHASE OF ESSENTIAL HYPERTENSION*. Ann Intern Med. 1954;41:50–69. doi: https://doi.org/10.7326/0003-4819-41-1-50
Download citation file:
Published: Ann Intern Med. 1954;41(1):50-69.
Adrenal Disorders, Cardiology, Coronary Risk Factors, Endocrine and Metabolism, Hypertension.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use